Key Highlights:
- Hearzap has completed the acquisition of Amplifon India’s hearing healthcare business, following the definitive agreement announced in May 2026. Backed by 360 ONE Asset Management, the deal adds approximately 240 hearing care points of sale, including 115 directly operated locations, along with experienced clinical teams and an established customer base.
- The acquisition expands Hearzap’s network to 420 centres across India with more than 1,000 service providers, taking it closer to its goal of 500 centres by 2027. The combined platform is expected to improve access to hearing care across metropolitan as well as Tier II and Tier III markets, while integrating Amplifon India’s clinical expertise and operational capabilities.
- Hearzap plans a phased 12-month integration while retaining existing Amplifon India professionals to ensure continuity of care. The combined business is expected to surpass ₹230 crore in revenue post-integration, with Hearzap targeting ₹250 crore by the end of the current financial year and nearly ₹500 crore by FY2029, supported by new centres, AI-enabled diagnostics, tele-audiology, rehabilitation services, training and expanded healthcare partnerships.
Implications:
Hearzap’s acquisition of Amplifon India’s hearing care business instantly adds ~240 points of sale (including 115 directly operated centres), clinical teams and an established customer base, taking Hearzap to 420 centres and >1,000 service providers, putting it on track for its 500‑centre by 2027 goal and making it one of India’s largest organized hearing networks. 1050 The combined platform (expected >₹230 crore revenue post‑integration, targeting ~₹250 crore this FY and ~₹500 crore by FY29) should improve access in metros and Tier II/III markets, while Hearzap’s planned 12‑month integration and retention of Amplifon staff aim to preserve continuity of care as it layers in AI diagnostics, tele‑audiology and expanded partnerships.
Source: Express Healthcare
